Aspira Women's Health Inc.
AWHL
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.31M | 9.18M | 8.96M | 8.92M | 8.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.31M | 9.18M | 8.96M | 8.92M | 8.99M |
| Cost of Revenue | 3.48M | 3.70M | 3.75M | 3.76M | 3.70M |
| Gross Profit | 5.83M | 5.48M | 5.21M | 5.16M | 5.29M |
| SG&A Expenses | 17.34M | 18.54M | 18.42M | 18.67M | 18.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.12M | 25.46M | 25.95M | 26.28M | 26.27M |
| Operating Income | -14.81M | -16.28M | -16.98M | -17.35M | -17.28M |
| Income Before Tax | -10.32M | -13.09M | -14.80M | -15.95M | -14.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.32 | -13.09 | -14.80 | -15.95 | -14.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.32M | -13.09M | -14.80M | -15.95M | -14.74M |
| EBIT | -14.81M | -16.28M | -16.98M | -17.35M | -17.28M |
| EBITDA | -14.73M | -16.19M | -16.87M | -17.22M | -17.12M |
| EPS Basic | -0.68 | -0.99 | -1.20 | -1.45 | -1.44 |
| Normalized Basic EPS | -0.50 | -0.69 | -0.79 | -0.94 | -1.01 |
| EPS Diluted | -0.68 | -0.99 | -1.20 | -1.45 | -1.44 |
| Normalized Diluted EPS | -0.50 | -0.69 | -0.79 | -0.94 | -1.01 |
| Average Basic Shares Outstanding | 66.23M | 56.49M | 50.18M | 44.55M | 40.43M |
| Average Diluted Shares Outstanding | 66.23M | 56.49M | 50.18M | 44.55M | 40.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |